End of the line for cannabinoid receptor 1 as an anti-obesity target? An opinion

被引：13
作者：
Bifulco, Maurizio [1 ]
Pisanti, Simona [1 ]
机构：
[1] Univ Salerno, Dept Pharmaceut Sci, Salerno, Italy
来源：
NATURE REVIEWS DRUG DISCOVERY | 2009年 / 8卷 / 07期
关键词：
D O I：
10.1038/nrd2775-c1
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
[No abstract available]
引用
收藏
页码：594 / 594
页数：1
相关论文
共 6 条
[1]   Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1) [J].
Barrero, FJ ;
Ampuero, I ;
Morales, B ;
Vives, F ;
del Castillo, JDL ;
Hoenicka, J ;
Yébenes, JG .
PHARMACOGENOMICS JOURNAL, 2005, 5 (02) :135-141
[2]   Overweight, obesity, and cancer risk [J].
Bianchini, F ;
Kaaks, R ;
Vainio, H .
LANCET ONCOLOGY, 2002, 3 (09) :565-574
[3]   Endocannabinoids in endocrine and related tumours [J].
Bifulco, Maurizio ;
Malfitano, Anna Maria ;
Pisanti, Simona ;
Laezza, Chiara .
ENDOCRINE-RELATED CANCER, 2008, 15 (02) :391-408
[4]   Rimonabant: Just an Antiobesity drug? Current evidence on its pleiotropic effects [J].
Bifulco, Maurizio ;
Grimaldi, Claudia ;
Gazzerro, Patrizia ;
Pisanti, Simona ;
Santoro, Antonietta .
MOLECULAR PHARMACOLOGY, 2007, 71 (06) :1445-1456
[5]   End of the line for cannabinoid receptor 1 as an anti-obesity target? [J].
Jones, Dan .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (12) :961-962
[6]   Antiangiogenic activity of the endocannabinoid anandamide: Correlation to its tumor-suppressor efficacy [J].
Pisanti, Simona ;
Borselli, Cristina ;
Oliviero, Olimpia ;
Laezza, Chiara ;
Gazzerro, Patrizia ;
Bifulco, Mauriz .
JOURNAL OF CELLULAR PHYSIOLOGY, 2007, 211 (02) :495-503
1